Rockaway, NJ, United States of America

Russell C Petter


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Russell C. Petter

Introduction

Russell C. Petter is a notable inventor based in Rockaway, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of improved processes for drug formulations. His work has the potential to enhance the efficacy and safety of various medical treatments.

Latest Patents

One of Russell C. Petter's key patents is titled "Improved process for preparing polymyxin B/dextran conjugates." This patent describes an innovative method for producing a water-soluble polymyxin B/dextran conjugate. The process involves reacting polymyxin B or a pharmaceutically acceptable salt thereof with dextran in an aqueous medium at a pH of about 9.3 to 10. This advancement could lead to more effective therapeutic applications of polymyxin B.

Career Highlights

Russell C. Petter is currently associated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to work on cutting-edge pharmaceutical research and development. With a focus on improving drug formulations, he has contributed to the advancement of medical science.

Collaborations

Throughout his career, Russell has collaborated with talented professionals in the field. Notable coworkers include Prasad Koteswara Kapa and Gleb Kardash, who have worked alongside him on various projects. These collaborations have fostered an environment of innovation and creativity.

Conclusion

Russell C. Petter's contributions to the pharmaceutical industry exemplify the impact of innovative thinking in medicine. His patent on the improved process for preparing polymyxin B/dextran conjugates showcases his commitment to enhancing drug formulations. Through his work at Novartis AG and collaborations with other professionals, he continues to make strides in the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…